ProVise Management Group LLC decreased its stake in Colgate-Palmolive (NYSE:CL) by 22.4% in the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 15,529 shares of the company’s stock after selling 4,475 shares during the quarter. ProVise Management Group LLC’s holdings in Colgate-Palmolive were worth $1,172,000 as of its most recent filing with the Securities & Exchange Commission.
Several other large investors also recently added to or reduced their stakes in the stock. Pacer Advisors Inc. lifted its stake in Colgate-Palmolive by 8.4% in the 2nd quarter. Pacer Advisors Inc. now owns 20,224 shares of the company’s stock worth $1,499,000 after acquiring an additional 1,566 shares in the last quarter. Point72 Asset Management L.P. purchased a new stake in Colgate-Palmolive in the 3rd quarter worth about $1,814,000. Fiduciary Trust Co. lifted its stake in Colgate-Palmolive by 1.6% in the 2nd quarter. Fiduciary Trust Co. now owns 170,818 shares of the company’s stock worth $12,663,000 after acquiring an additional 2,758 shares in the last quarter. The Manufacturers Life Insurance Company lifted its stake in Colgate-Palmolive by 10.3% in the 2nd quarter. The Manufacturers Life Insurance Company now owns 1,131,987 shares of the company’s stock worth $83,914,000 after acquiring an additional 105,878 shares in the last quarter. Finally, Pensionfund DSM Netherlands purchased a new stake in shares of Colgate-Palmolive during the 3rd quarter worth about $4,225,000. Institutional investors and hedge funds own 72.91% of the company’s stock.
Colgate-Palmolive (CL) traded down $0.18 during mid-day trading on Wednesday, hitting $69.46. The stock had a trading volume of 151,279 shares, compared to its average volume of 4,008,444. The company has a current ratio of 1.36, a quick ratio of 1.00 and a debt-to-equity ratio of 27.02. Colgate-Palmolive has a 12 month low of $68.19 and a 12 month high of $77.91. The company has a market capitalization of $61,334.14, a P/E ratio of 30.45, a P/E/G ratio of 2.59 and a beta of 0.79.
Colgate-Palmolive (NYSE:CL) last announced its quarterly earnings data on Friday, January 26th. The company reported $0.75 EPS for the quarter, hitting analysts’ consensus estimates of $0.75. Colgate-Palmolive had a return on equity of 1,716.69% and a net margin of 13.10%. The business had revenue of $3.89 billion during the quarter, compared to analysts’ expectations of $3.92 billion. During the same period in the previous year, the firm earned $0.75 earnings per share. The firm’s quarterly revenue was up 4.6% compared to the same quarter last year. analysts predict that Colgate-Palmolive will post 3.18 EPS for the current year.
The firm also recently announced a quarterly dividend, which was paid on Thursday, February 15th. Shareholders of record on Tuesday, January 23rd were paid a $0.40 dividend. The ex-dividend date of this dividend was Monday, January 22nd. This represents a $1.60 dividend on an annualized basis and a yield of 2.30%. Colgate-Palmolive’s payout ratio is 70.18%.
A number of brokerages recently weighed in on CL. Zacks Investment Research raised Colgate-Palmolive from a “hold” rating to a “buy” rating and set a $84.00 price objective on the stock in a research note on Monday, January 8th. Macquarie raised Colgate-Palmolive from a “neutral” rating to an “outperform” rating and set a $81.00 target price on the stock in a report on Tuesday, December 19th. BNP Paribas lowered Colgate-Palmolive from an “outperform” rating to an “underperform” rating in a report on Tuesday, January 30th. Citigroup lifted their price objective on Colgate-Palmolive from $75.00 to $80.00 and gave the stock a “neutral” rating in a report on Tuesday, January 30th. Finally, Deutsche Bank started coverage on Colgate-Palmolive in a report on Wednesday, December 13th. They set a “hold” rating and a $75.00 price objective on the stock. Three analysts have rated the stock with a sell rating, ten have given a hold rating and five have issued a buy rating to the company. The stock has an average rating of “Hold” and a consensus price target of $77.91.
In other news, insider Jennifer Daniels sold 902 shares of the company’s stock in a transaction dated Tuesday, January 9th. The stock was sold at an average price of $75.82, for a total transaction of $68,389.64. Following the completion of the transaction, the insider now directly owns 37,788 shares of the company’s stock, valued at $2,865,086.16. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, insider Daniel B. Marsili sold 5,692 shares of the company’s stock in a transaction dated Wednesday, February 21st. The stock was sold at an average price of $70.19, for a total value of $399,521.48. Following the transaction, the insider now directly owns 41,677 shares of the company’s stock, valued at $2,925,308.63. The disclosure for this sale can be found here. Over the last three months, insiders sold 463,082 shares of company stock valued at $32,983,130. Insiders own 1.02% of the company’s stock.
Colgate-Palmolive Company (Colgate) is a consumer products company. The Company operates in two product segments: Oral, Personal and Home Care, and Pet Nutrition. The Oral, Personal and Home Care product segment is operated through five geographic segments, which include North America, Latin America, Europe, Asia Pacific and Africa/Eurasia.